Abeona Therapeutics Inc.

ABEO Nasdaq SEC CIK 318306
Follow Abeona Therapeutics Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $13.5M
Net income −$4.8M +6.8% vs same quarter last year
EPS, diluted −$0.08 +20% vs same quarter last year
Operating cash flow −$8.3M +60.8% vs same quarter last year
Revenue by quarter
$400K
$0
$5.4M
$8.7M
$11.4M
$13.5M
Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$100M−$75M−$50M−$25M$0$25MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$5.8M-
FY24--
FY23$3.5M-
FY22$1.4M−$39.7M
FY21$3M−$84.9M
FY20$10M−$84.2M
FY19-−$76.3M
FY18$3M−$56.7M
FY17$837K−$27.3M
FY16$889K−$21.9M
FY15$1M−$14.5M
FY14$925K−$26.8M
FY13$2M$4.4M
FY12$4.4M−$10.5M
FY11$1.8M−$2.5M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−4000%−3000%−2000%−1000%0%1000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2573.7%−1536.9%-
FY24---
FY23-−1346.7%-
FY22-−3600.8%−2807.4%
FY21-−2994.5%−2831.2%
FY20-−814.2%−842.3%
FY19---
FY18-−1940.2%−1890.3%
FY17-−3325.7%−3263.9%
FY16-−2686.3%−2460.4%
FY15-−1783.3%−1396.7%
FY14100%−338.5%−2894.9%
FY1393.9%−186.3%217.9%
FY1293.9%−98%−239.1%
FY1192%−428.3%−137.7%
Free cash flowOperating cash flow minus capital expenditure
−$100M−$75M−$50M−$25M$0FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$84.3M
FY24−$58.5M
FY23−$37.3M
FY22−$43.6M
FY21−$69.8M
FY20−$36.4M
FY19−$69.1M
FY18−$48.4M
FY17−$23.5M
FY16−$13.5M
FY15−$10.7M
FY14−$1.6M
FY13−$1K
FY12−$4M
FY11−$7.6M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Abeona Therapeutics
  • Healthcare median
−4000%−3000%−2000%−1000%0%1000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearAbeona TherapeuticsHealthcare median
FY25-−30.6%
FY24-−47%
FY23-−58%
FY22−2807.4%−80.4%
FY21−2831.2%−71.9%
FY20−842.3%−62.2%
FY19-−46.3%
FY18−1890.3%−49.6%
FY17−3263.9%−45.9%
FY16−2460.4%−36%
FY15−1396.7%−38.4%
FY14−2894.9%−35.5%
FY13217.9%−37.1%
FY12−239.1%−29.1%
FY11−137.7%−27.9%